药学学报b审稿周期

是核心期刊药学学报《药学学报》创刊于1953年7月，是中国自然科学核心期刊、中文核心期刊，其前身是我国历史最悠久的学术期刊《中华药学杂志》（1936年创刊）。本刊为报道我国药学科研成果、促进国内外学术交流的综合性学术刊物，国主管主办：中国科学技术协会 中国药学会快捷分类：医学药学 医药卫生科技出版发行：北京 月刊 A4期刊刊号：0513-4870,11-2163/R创刊时间：1953 影响因子028审稿时间：1-3个月期刊级别： CSCD核心期刊　 北大核心期刊　 统计源期刊

不是。药学学报英文版ISSN:2211-3835EISSN: 2211-3843CN: 10-1171/RSponsored byChinese Pharmaceutical AssociationInstitute of MateriaMedica, Chinese Academic of Medical SciencesPublished jointly byChinese Pharmaceutical Journal C, LElsevier BVEdited by Editorial Office of Acta Pharmaceutica SinicaActa Pharmaceutica Sinica B (APSB) is a bimonthly English peer-reviewed online journal in ScienceDirect, which publishes significant original research articles, communications and high quality reviews of recent APSB encourages submissions from all areas of pharmaceutical sciences, including pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis and APSB is a part of the series Acta Pharmaceutica Sinica, which was founded in The journal is co-published by Elsevier BV, in association with the Institute of MateriaMedica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical A